Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
It is unknown how dogs with hyperadrenocorticism (HAC) respond to vaccination. This study measured antibodies against canine parvovirus (CPV) in dogs with HAC treated with trilostane before and after CPV vaccination, and compared the immune response to that from healthy dogs. Eleven dogs with HAC, a...
Main Authors: | Michèle Bergmann, Monika Freisl, Katrin Hartmann, Stephanie Speck, Uwe Truyen, Yury Zablotski, Matthias Mayr, Astrid Wehner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/3/547 |
Similar Items
-
Antibody Response to Canine Parvovirus Vaccination in Dogs with Hypothyroidism Treated with Levothyroxine
by: Michèle Bergmann, et al.
Published: (2021-02-01) -
Comparison of Four Commercially Available Point-of-Care Tests to Detect Antibodies against Canine Parvovirus in Dogs
by: Michèle Bergmann, et al.
Published: (2020-12-01) -
Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
by: Carolina Arenas Bermejo, et al.
Published: (2020-07-01) -
Retrospective study on trilostane titration dose treatment in dogs with terminal stage of hyperadrenocorticism
by: Irena Celeska, et al.
Published: (2024-03-01) -
Comparison of Eight Commercially Available Faecal Point-of-Care Tests for Detection of Canine Parvovirus Antigen
by: Julia Walter-Weingärtner, et al.
Published: (2021-10-01)